116 related articles for article (PubMed ID: 8876669)
21. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.
Yang P; Kollmeyer TM; Buckner K; Bamlet W; Ballman KV; Jenkins RB
Cancer; 2005 Jun; 103(11):2363-72. PubMed ID: 15834925
[TBL] [Abstract][Full Text] [Related]
23. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
24. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.
Wei Q; Bondy ML; Mao L; Gaun Y; Cheng L; Cunningham J; Fan Y; Bruner JM; Yung WK; Levin VA; Kyritsis AP
Cancer Res; 1997 May; 57(9):1673-7. PubMed ID: 9135006
[TBL] [Abstract][Full Text] [Related]
25. Mismatch repair protein hMSH2 in primary drug resistance in in vitro human malignant gliomas.
Rellecke P; Kuchelmeister K; Schachenmayr W; Schlegel J
J Neurosurg; 2004 Oct; 101(4):653-8. PubMed ID: 15481721
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
Fults D; Pedone C
Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
[TBL] [Abstract][Full Text] [Related]
27. Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.
Cai J; Chen J; Zhang W; Yang P; Zhang C; Li M; Yao K; Wang H; Li Q; Jiang C; Jiang T
Oncotarget; 2015 Jul; 6(20):18105-15. PubMed ID: 25971279
[TBL] [Abstract][Full Text] [Related]
28. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
Yu S; Pu P; Jiang D; An T; Guan X; Yang L
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract][Full Text] [Related]
30. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.
Hirvonen HE; Salonen R; Sandberg MM; Vuorio E; Västrik I; Kotilainen E; Kalimo H
Br J Cancer; 1994 Jan; 69(1):16-25. PubMed ID: 8286200
[TBL] [Abstract][Full Text] [Related]
32. Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing.
Calmels N; Greff G; Obringer C; Kempf N; Gasnier C; Tarabeux J; Miguet M; Baujat G; Bessis D; Bretones P; Cavau A; Digeon B; Doco-Fenzy M; Doray B; Feillet F; Gardeazabal J; Gener B; Julia S; Llano-Rivas I; Mazur A; Michot C; Renaldo-Robin F; Rossi M; Sabouraud P; Keren B; Depienne C; Muller J; Mandel JL; Laugel V
Orphanet J Rare Dis; 2016 Mar; 11():26. PubMed ID: 27004399
[TBL] [Abstract][Full Text] [Related]
33. Genetic Variants Related to Cell Cycle and Stability of Telomere in Patients with Glioma.
Calastri MCJ; Hattori G; Rodrigues NLTO; Gregorio ML; Brancati CIFO; Zanovelo EM; Ferraz Filho JRL; Neiva CM; Rodrigues Junior ACP; de Godoy MF; Lancellotti CLP; Tognola WA; Souza DRS
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2345-2351. PubMed ID: 31450905
[TBL] [Abstract][Full Text] [Related]
34. Heparanase expression of glioma in human and animal models.
Hong X; Nelson KK; deCarvalho AC; Kalkanis SN
J Neurosurg; 2010 Aug; 113(2):261-9. PubMed ID: 19835469
[TBL] [Abstract][Full Text] [Related]
35. Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer's disease.
Hermon M; Cairns N; Egly JM; Fery A; Labudova O; Lubec G
Neurosci Lett; 1998 Jul; 251(1):45-8. PubMed ID: 9714461
[TBL] [Abstract][Full Text] [Related]
36. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
37. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
Born PW; Broholm H; Laursen H
Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
[TBL] [Abstract][Full Text] [Related]
38. Structure and expression of the excision repair gene ERCC6, involved in the human disorder Cockayne's syndrome group B.
Troelstra C; Hesen W; Bootsma D; Hoeijmakers JH
Nucleic Acids Res; 1993 Feb; 21(3):419-26. PubMed ID: 8382798
[TBL] [Abstract][Full Text] [Related]
39. Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth.
Yu M; Bell RH; Ho MM; Leung G; Haegert A; Carr N; Shapiro J; McElwee KJ
PLoS One; 2012; 7(5):e34185. PubMed ID: 22615732
[TBL] [Abstract][Full Text] [Related]
40. Analysis of DNA repair gene polymorphisms in glioblastoma.
Rodriguez-Hernandez I; Perdomo S; Santos-Briz A; Garcia JL; Gomez-Moreta JA; Cruz JJ; Gonzalez-Sarmiento R
Gene; 2014 Feb; 536(1):79-83. PubMed ID: 24325908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
